W. E. Lands, Long-term fat intake and biomarkers, Am, J. Clin. Nutr, vol.61, pp.721-725, 1995.

S. I. Rapoport, In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism, The Journal of Pediatrics, vol.143, issue.4, pp.26-34, 2003.
DOI : 10.1067/S0022-3476(03)00399-8

E. J. Goetzl, S. , and W. L. Smith, Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases, FASEB J, vol.9, pp.1051-1058, 1995.

H. C. Yang, M. Mosior, C. A. Johnson, Y. Chen, and E. A. Dennis, Group-Specific Assays That Distinguish between the Four Major Types of Mammalian Phospholipase A2, Analytical Biochemistry, vol.269, issue.2
DOI : 10.1006/abio.1999.4053

J. D. Clark, L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman et al., A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP, Cell, vol.65, issue.6, pp.1043-1051, 1991.
DOI : 10.1016/0092-8674(91)90556-E

K. S. Authi, M. Lagarde, and N. Crawford, Diacylglycerol lipase activity in human platelet intracellular and surface membranes, FEBS Letters, vol.222, issue.1, pp.95-101, 1985.
DOI : 10.1016/0014-5793(85)80239-8

A. Cane, M. Breton, K. Koumanov, G. Béréziat, and O. Colard, Oxidant-induced arachidonic acid release and impairment of fatty acid acylation in vascular smooth muscle cells, Am. J

C. M. Markey, A. Alward, P. E. Weller, and L. J. Marnett, Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities, J. Biol. Chem, vol.262, pp.6266-6279, 1987.

M. Hamberg, J. Svensson, and B. Samuelsson, Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. U. S

S. J. Gray and S. Heptinstall, Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP, European Journal of Pharmacology, vol.194, issue.1, pp.63-70, 1991.
DOI : 10.1016/0014-2999(91)90124-9

D. C. Mills and D. E. Macfarlane, Stimulation of human platelet adenylate cyclase by prostaglandin D2, Thrombosis Research, vol.5, issue.3, pp.401-412, 1975.
DOI : 10.1016/0049-3848(74)90176-5

S. Narumiya, Y. Sugimoto, and F. Ushikubi, Prostanoid Receptors., Annals of the New York Academy of Sciences, vol.267, issue.1 Cellular Gene, pp.1193-1226, 1999.
DOI : 10.1016/0014-2999(79)90162-6

M. Amin, Simultaneous determination of prostaglandins (PG) E2, A2 and B2 and stability studies of PGE2 in pharmaceutical preparations by ion-pair reversed phase HPLC

M. Fukushima, Biological activities and mechanisms of action of PGJ2 and related compounds: an update, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.47, issue.1, pp.1-12, 1992.
DOI : 10.1016/0952-3278(92)90178-L

T. Ide, K. Egan, L. C. Bell-parikh, and G. A. Fitzgerald, Activation of nuclear receptors by prostaglandins, Thrombosis Research, vol.110, issue.5-6, pp.311-315, 2003.
DOI : 10.1016/S0049-3848(03)00418-3

M. Lagarde, Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function, Progress in Lipid Research, vol.27, issue.2, pp.135-152, 1988.
DOI : 10.1016/0163-7827(88)90008-2

K. Watanabe, Prostaglandin F synthase, Prostaglandins Other Lipid Mediat, pp.68-69, 2002.

Y. Kanaoka and Y. Urade, Hematopoietic prostaglandin D synthase,ProstaglandinsLeukot. Essent. Fat, pp.163-167, 2003.
DOI : 10.1016/s0952-3278(03)00077-2

S. Hara, D. Kamei, Y. Sasaki, A. Tanemoto, Y. Nakatani et al., Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models, Biochimie, vol.92, issue.6, pp.651-659, 2010.
DOI : 10.1016/j.biochi.2010.02.007

W. C. Chang, J. Nakao, H. Orimo, and S. Murota, Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets, Biochemical Journal, vol.202, issue.3, pp.771-776, 1982.
DOI : 10.1042/bj2020771

C. Calzada, E. Véricel, B. Mitel, L. Coulon, and M. Lagarde, (S)- Hydroperoxyeicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets, J. Lipid Res, vol.4, pp.12-1467, 2001.

M. Croset, A. Sala, G. Folco, and M. Lagarde, Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988.
DOI : 10.1016/0006-2952(88)90782-4

P. Fonlupt, M. Croset, and M. Lagarde, 12-HETE inhibits the binding of PGH2/TxA2 receptor ligands in human platelets, Thrombosis Research, vol.63, issue.2, pp.239-248, 1991.
DOI : 10.1016/0049-3848(91)90287-7

J. Nowak and G. A. Fitzgerald, Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man., Journal of Clinical Investigation, vol.83, issue.2, pp.380-385, 1989.
DOI : 10.1172/JCI113895

Z. Soussi, O. Dominguez, M. Macovschi, G. Dubois, M. Nemoz et al., Mechanisms involved in the stimulation of prostacyclin synthesis by human lymphocytes in human umbilical vein endothelial cells, British Journal of Pharmacology, vol.157, issue.2, pp.321-328, 2003.
DOI : 10.1038/sj.bjp.0705253

S. L. Hong, T. Carty, and D. Deykin, Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells, J. Biol. Chem, vol.255, pp.9538-9540, 1980.

W. Lands, R. Lee, and W. Smith, FACTORS REGULATING THE BIOSYNTHESIS OF VARIOUS PROSTAGLANDINS, Annals of the New York Academy of Sciences, vol.3, issue.1 Prostaglandin, pp.107-122, 1971.
DOI : 10.1002/anie.196901671

B. Samuelsson, Leukotrienes: Mediators of Allergic Reactions and Inflammation, International Archives of Allergy and Immunology, vol.66, issue.1
DOI : 10.1159/000232880

O. Rådmark, C. Malmsten, B. Samuelsson, D. A. Clark, G. Goto et al., Leu kotriene A: stereochemistry and enzymatic conversion to leukotriene B4, Biochem. Biophys

A. W. Ford-hutchinson, A. Rackham, R. Zamboni, J. Rokach, and S. Roy, Comparative biological activities of synthetic leukotriene b4 and its ??-oxidation products, Prostaglandins, vol.25, issue.1, pp.29-37, 1983.
DOI : 10.1016/0090-6980(83)90132-6

P. Borgeat, B. Fruteaudelaclos, S. Picard, J. Drapeau, P. Vallerandand et al., Studies on the mechanism of formation of the 5S, Prostaglandins, vol.126810, issue.23, pp.14-713, 1982.

M. Croset and M. Lagarde, Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids, Biochemical and Biophysical Research Communications, vol.112, issue.3, pp.878-883, 1983.
DOI : 10.1016/0006-291X(83)91699-6

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.382-388, 2011.
DOI : 10.1096/fj.10-161836

URL : https://hal.archives-ouvertes.fr/inserm-00517396

W. S. Powell, M. Hashefi, J. R. Falck, K. Chauhan, J. Rokach et al., Mac Leod, Effects of oxo and dihydro metabolites of 12-hydroxy-5, acid on chemotaxis and cytosolic calcium levels in human neutrophils, J. Leukoc, p.14

W. S. Powell and J. Rokach, The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor, Progress in Lipid Research, vol.52, issue.4, pp.651-665, 2013.
DOI : 10.1016/j.plipres.2013.09.001

O. Rådmark, C. Malmsten, and B. Samuelsson, Leukotriene A4: Enzymatic conversion to leukotriene C4, Biochemical and Biophysical Research Communications, vol.96, issue.4, pp.1679-1687, 1980.
DOI : 10.1016/0006-291X(80)91367-4

B. Samuelsson, S. E. Dahlén, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan, Leukotrienes and lipoxins: structures, biosynthesis, and biological effects, Science, vol.237, issue.4819, pp.1171-1176, 1987.
DOI : 10.1126/science.2820055

R. C. Murphy and M. A. Gijón, Biosynthesis and metabolism of leukotrienes, Biochem

H. S. Hansen, 15-Hydroxyprostaglandin dehydrogenase. A review, Prostaglandins, vol.12, issue.4, pp.647-679, 1976.
DOI : 10.1016/0090-6980(76)90044-7

S. E. Barrow, J. Cockcroft, C. T. Dollery, N. E. Hickling, and J. M. Ritter, Identification of 13,14-dihydro-15-oxo-prostaglandin F2?? in the circulation during infusions of bradykinin and prostaglandin E2 in man, British Journal of Pharmacology, vol.260, issue.1, pp.245-250, 1987.
DOI : 10.1111/j.1476-5381.1987.tb09005.x

U. Diczfalusy and S. E. Alexson, Identification of metabolites from peroxisomal beta-oxidation of prostaglandins, J. Lipid Res, vol.31, pp.307-314, 1990.

U. Diczfalusy, ??-Oxidation of eicosanoids, Progress in Lipid Research, vol.33, issue.4, pp.403-428, 1994.
DOI : 10.1016/0163-7827(94)90025-6

T. L. Kaduce, X. Fang, S. D. Harmon, C. L. Oltman, K. C. Dellsperger et al., 20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells, Journal of Biological Chemistry, vol.279, issue.4, pp.2648-2656, 2004.
DOI : 10.1074/jbc.M306849200

J. H. Capdevila, J. R. Falck, and R. W. Estabrook, Cytochrome P450 and the arachidonate cascade, FASEB J, vol.6, pp.731-736, 1992.

E. H. Oliw, Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenates, Progress in Lipid Research, vol.33, issue.3, pp.329-354, 1994.
DOI : 10.1016/0163-7827(94)90029-9

J. D. Imig, Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology, Physiological Reviews, vol.92, issue.1, pp.101-130, 2012.
DOI : 10.1152/physrev.00021.2011

D. F. Horrobin, Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.44, issue.2, pp.127-131, 1991.
DOI : 10.1016/0952-3278(91)90196-C

M. Lagarde, A. Gharib, and M. Dechavanne, Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase, Biochimie, vol.59, issue.11-12, pp.935-937, 1977.
DOI : 10.1016/S0300-9084(78)80710-X

P. Needleman, M. O. Whitaker, A. Wyche, K. Watters, H. Sprecherand et al., Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: Pharmacological basis for a therapeutic approach, Prostaglandins, vol.19, issue.1, pp.165-181, 1980.
DOI : 10.1016/0090-6980(80)90163-X

S. M. Wolfe and N. R. Shulman, Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP, Biochemical and Biophysical Research Communications, vol.41, issue.1, pp.128-134, 1970.
DOI : 10.1016/0006-291X(70)90478-X

P. Needleman, M. Minkes, and A. Raz, Thromboxanes: selective biosynthesis and distinct biological properties, Science, vol.193, issue.4248, pp.163-165, 1976.
DOI : 10.1126/science.945611

S. Fischer and P. C. Weber, Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid, Nature, vol.116, issue.5947, pp.165-168, 1984.
DOI : 10.1038/307165a0

M. O. Whitaker, A. Wyche, F. Fitzpatrick, H. Sprecher, and P. Needleman, Triene prostaglandins: Prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances, Proceedings of the National Academy of Sciences, vol.76, issue.11, pp.5919-5923, 1979.
DOI : 10.1073/pnas.76.11.5919

S. P. Tull, C. M. Yates, B. H. Maskrey, V. B. O-'donnell, J. Madden et al., Omega-3 Fatty Acids and Inflammation: Novel Interactions Reveal a New Step in Neutrophil Recruitment, PLoS Biology, vol.45, issue.8, p.1000177, 2009.
DOI : 10.1371/journal.pbio.1000177.t003

J. Lefilslacourtablaise, M. Socorro, A. Géloën, P. Daira, C. Debard et al., The Eicosapentaenoic Acid Metabolite 15-Deoxy-??12,14-Prostaglandin J3 Increases Adiponectin Secretion by Adipocytes Partly via a PPAR??-Dependent Mechanism, PLoS ONE, vol.173, issue.5, p.63997, 2013.
DOI : 10.1371/journal.pone.0063997.t001

D. Bagga, L. Wang, R. Farias-eisner, J. A. Glaspy, and S. T. Reddy, Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX

M. Vanrollins, L. Horrocks, and H. Sprecher, 16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets, Biochim. Biophys. Acta, vol.1013, issue.833, pp.272-280, 1985.

R. Harkewicz, E. Fahy, A. Andreyev, and E. A. Dennis, Arachidonate-derived Dihomoprostaglandin Production Observed in Endotoxin-stimulated Macrophage-like Cells, Journal of Biological Chemistry, vol.282, issue.5
DOI : 10.1074/jbc.M610067200

W. B. Campbell, J. R. Falck, J. R. Okita, A. R. Johnson, and K. S. Callahan, Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.837, issue.1, pp.67-76, 1985.
DOI : 10.1016/0005-2760(85)90086-4

H. Sprecher and M. M. Careaga, Metabolism of (n-6) and (n-3) polyunsaturated fatty acids by human platelets, Prostaglandins, Leukotrienes and Medicine, vol.23, issue.2-3, pp.129-134, 1986.
DOI : 10.1016/0262-1746(86)90175-7

K. F. Drazen, . A. Austen-andr, and . Lewis, Immunologically induced generation of tetraene and pentaene leukotrienes in the peritoneal cavities of menhaden-fed rats, J

T. H. Lee, J. M. Mencia-huerta, C. Shih, E. J. Corey, R. A. Lewisand et al., Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product, J. Biol. Chem, vol.259, pp.2383-2389, 1984.

J. L. Wallace and G. W. Mcknight, Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach, Journal of Experimental Medicine, vol.171, issue.5
DOI : 10.1084/jem.171.5.1827

M. Vanrollins, Synthesis and characterization of cytochrome P-450 epoxygenase metabolites of eicosapentaenoic acid, Lipids, vol.146, issue.8, pp.481-490, 1990.
DOI : 10.1007/BF02538092

C. N. Serhan, S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand et al., Resolvins, The Journal of Experimental Medicine, vol.71, issue.8
DOI : 10.1084/jem.183.1.137

S. F. Oh, T. W. Vickery, and C. N. Serhan, Chiral lipidomics of E-series resolvins: Aspirin and the biosynthesis of novel mediators, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1811, issue.11, pp.1811-737, 2011.
DOI : 10.1016/j.bbalip.2011.06.007

M. Hamberg, Steric analysis of hydroperoxides formed by lipoxygenase oxygenation of linoleic acid, Analytical Biochemistry, vol.43, issue.2, pp.515-526, 1971.
DOI : 10.1016/0003-2697(71)90282-X

M. R. Buchanan, T. A. Haas, M. Lagarde, and M. Guichardant, 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX, J. Biol. Chem, vol.260, pp.16056-16059, 1985.

M. Hamberg and B. Samuelsson, Stereochemistry in the formation of [9-hydroxy-10,12-octadecadienoic acid and 13-hydroxy-9,11-octadecadienoic acid from linoleic acid by fatty acid cyclooxygenase, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.617, issue.3, pp.545-547, 1980.
DOI : 10.1016/0005-2760(80)90022-3

T. L. Kaduce, P. H. Figard, R. Leifur, and A. A. Spector, Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells, J. Biol. Chem, vol.264, pp.6823-6830, 1989.

Q. H. Lê, M. Elalaoui, E. Véricel, B. Ségrestin, L. Soulère et al., Glycoxidized HDL, HDL Enriched With Oxidized Phospholipids and HDL From Diabetic Patients Inhibit Platelet Function, The Journal of Clinical Endocrinology & Metabolism, vol.100, issue.5, pp.2006-2014, 2015.
DOI : 10.1210/jc.2014-4214

S. C. Cunnane, New Developments in α-Linolenate Metabolism with Emphasis on the Importance of β-Oxidation and Carbon Recycling, World Rev. Nutr. Diet, vol.88, pp.178-183, 2001.
DOI : 10.1159/000059751

G. Burdge, ??-Linolenic acid metabolism in men and women: nutritional and biological implications, Current Opinion in Clinical Nutrition and Metabolic Care, vol.7, issue.2, pp.137-144, 2004.
DOI : 10.1097/00075197-200403000-00006

M. Liu, P. Chen, E. Véricel, M. Lelli, L. Béguin et al., Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA, The Journal of Lipid Research, vol.54, issue.8, pp.2083-2094, 2013.
DOI : 10.1194/jlr.M035139

URL : https://hal.archives-ouvertes.fr/inserm-00832286

C. Schneider and A. R. Brash, Stereospecificity of Hydrogen Abstraction in the Conversion of Arachidonic Acid to 15R-HETE by Aspirin-treated Cyclooxygenase-2. IMPLICATIONS FOR THE ALIGNMENT OF SUBSTRATE IN THE ACTIVE SITE, Journal of Biological Chemistry, vol.275, issue.7, pp.4743-4746, 2000.
DOI : 10.1074/jbc.275.7.4743

W. O. Lundberg, The Significance of cis, cis, cis 5,8,11 Eicosatrienoic Acid in Essential Fatty Acid Deficiency, Nutrition Reviews, vol.38, issue.7, pp.233-235, 1980.
DOI : 10.1111/j.1753-4887.1980.tb05910.x

B. A. Jakschik, A. R. Morrison, and H. Sprecher, Products derived from 511-eicosatrienoic acid by the 5-lipoxygenaseleukotriene pathway, J. Biol. Chem, vol.8, issue.258, pp.12797-12800, 1983.

S. Hammarström, 11-eicosatrienoic acid to leukotrienes C3 and D3, J. Biol. Chem, vol.8, issue.256, pp.2275-2279, 1981.

N. Salem, J. Litman, H. Y. Kim, and K. Gawrisch, Mechanisms of action of docosahexaenoic acid in the nervous system, Lipids, vol.68, issue.9, pp.945-959, 2001.
DOI : 10.1007/s11745-001-0805-6

T. H. Lee, J. M. Drazen, R. A. Lewis, and K. F. Austen, Substrate and regulatory functions of eicosapentaenoic and docosahexaenoic acids for the 5-lipoxygenase pathway. Implications for pulmonary responses, Prog. Biochem. Pharmacol, vol.20, pp.1-17, 1985.

C. M. Connor, E. Aderman, A. Liclican, D. Carughi, Y. Perelman et al., 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ?-3 polyunsaturated fatty acids, Sci. Transl. Med, vol.3, pp.69-81, 2011.

M. I. Aveldaño and H. Sprecher, Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1- 14C] docosahexaenoic acid by human platelets, J. Biol. Chem, vol.258, pp.9339-9343, 1983.

P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.3478-3484, 2009.
DOI : 10.1016/j.febslet.2009.10.004

URL : https://hal.archives-ouvertes.fr/inserm-00429322

C. N. Serhan and N. Chiang, Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus, British Journal of Pharmacology, vol.76, issue.69, pp.200-215, 2008.
DOI : 10.1038/sj.bjp.0707489

M. Morita, K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira et al., The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza, Cell, vol.153, issue.1, pp.112-125, 2013.
DOI : 10.1016/j.cell.2013.02.027

Y. Imai, Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.4, pp.496-502, 1851.
DOI : 10.1016/j.bbalip.2015.01.006

B. Amand, A. Marcotte, and . Marette, Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis, Nat. Med, vol.20, pp.664-669, 2014.

C. N. Serhan, R. Yang, K. Martinod, K. Kasuga, P. S. Pillai et al., Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions, The Journal of Experimental Medicine, vol.192, issue.1, pp.15-23, 2009.
DOI : 10.1016/S0076-6879(07)32012-0

B. Deng, C. W. Wang, H. H. Arnardottir, Y. Li, C. Y. Cheng et al., Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages, PLoS ONE, vol.1133, issue.7, 2014.
DOI : 10.1371/journal.pone.0102362.s002

M. Arita, C. B. Clish, and C. N. Serhan, The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3

R. R. Ji, Z. Z. Xu, G. Strichartz, and C. N. Serhan, Emerging roles of resolvins in the resolution of inflammation and pain, Trends Neurosci, pp.599-609, 2011.

R. A. Colas, M. Shinohara, J. Dalli, N. Chiang, and C. N. Serhan, Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue, AJP: Cell Physiology, vol.307, issue.1
DOI : 10.1152/ajpcell.00024.2014

C. Skarke, N. Alamuddin, J. A. Lawson, J. F. Ferguson, M. P. Reilly et al., Bioacti ve products formed in humans from fish oils, J. Lipid Res, 2015.

M. Guichardant and M. Lagarde, Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.836, issue.2, pp.210-214, 1985.
DOI : 10.1016/0005-2760(85)90068-2

B. Dangi, M. Obeng, J. M. Nauroth, M. Teymourlouei, M. Needham et al., Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6), Journal of Biological Chemistry, vol.284, issue.22, pp.14744-14759, 2009.
DOI : 10.1074/jbc.M809014200

J. Dalli, R. A. Colas, and C. N. Serhan, Novel n-3 Immunoresolvents: Structures and Actions, Scientific Reports, vol.7, 1940.
DOI : 10.1038/srep01940

B. Dangi, M. Obeng, J. M. Nauroth, G. Chung, E. Baileyhall et al., Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6), Biochemical Pharmacology, vol.79, issue.2, pp.251-260, 2010.
DOI : 10.1016/j.bcp.2009.08.001

L. J. Roberts and J. P. Ii, The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation, Chemistry and Physics of Lipids, vol.128, issue.1-2, pp.173-186, 2004.
DOI : 10.1016/j.chemphyslip.2003.09.016

J. Roy, J. Y. Leguennec, J. M. Galano, J. Thireau, V. Bultelponcé et al., Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?, Biochimie, vol.120, 2015.
DOI : 10.1016/j.biochi.2015.06.010

G. L. Milne, Q. Dai, L. J. Roberts, and . Ii, The isoprostanes???25 years later, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.4, pp.1851-433, 2015.
DOI : 10.1016/j.bbalip.2014.10.007

J. M. Galano, J. C. Lee, C. Gladine, B. Comte, J. Y. Leguennec et al., Nonenzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and ?-linolenic acids; bioactivities and potential use as biomarkers